Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Veeva SystemsBSP:V2EE34 -0.79%96 Piotroski F-Score is 4 as of Sep. 03, 2026, which is 33% below its 10-year median of 6.00. GuruFocus rates BSP:V2EE34 with a GF Score™ of 96/100 and a GF Value™ of R$44.73 (Fairly Valued). The stock has 2 warning signs investors should review. Among 645 Healthcare Providers & Services companies, Veeva Systems ranks worse than 68.84% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Veeva Systems has an F-score of 4 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for Veeva Systems's Piotroski F-Score or its related term are showing as below:
BSP:V2EE34'
s Piotroski F-Score Range Over the Past 10 Years
Min: 3 Med: 6 Max: 8
Current: 4
During the past 13 years, the highest Piotroski F-Score of Veeva Systems was 8. The lowest was 3. And the median was 6.
Veeva Systems (BSP:V2EE34) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Veeva Systems Piotroski F-Score Related Terms
Veeva Systems Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Veeva Systems's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:V2EE34 vs BTSG, TEM, TXG: Piotroski F-Score Comparison
For the Health Information Services subindustry, Veeva Systems's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veeva Systems Piotroski F-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Veeva Systems's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Jul26) TTM:
Last Year (Jul25) TTM:
Net Income was 1271.528 + 1301.998 + 1313.526 + 1397.058 = R$5,284 Mil. Cash Flow from Operations was 1037.811 + 569.665 + 5673.789 + 1219.66 = R$8,501 Mil. Revenue was 4367.046 + 4456.956 + 4444.672 + 4741.334 = R$18,010 Mil. Gross Profit was 3293.286 + 3318.782 + 3332.563 + 3555.892 = R$13,501 Mil.
Average Total Assets from the begining of this year (Jul25)
to the end of this year (Jul26) was
(44262.429 + 43588.583 + 47874.265 + 45957.282 + 46292.303) / 5 = R$45594.9724 Mil. Total Assets at the begining of this year (Jul25) was R$44,262 Mil. Long-Term Debt & Capital Lease Obligation was R$700 Mil. Total Current Assets was R$40,600 Mil. Total Current Liabilities was R$7,439 Mil.
Net Income was 1045.69 + 1175.882 + 1321.334 + 1108.35 = R$4,651 Mil.
Revenue was 3934.997 + 4333.174 + 4395.238 + 4366.143 = R$17,030 Mil. Gross Profit was 2953.571 + 3245.255 + 3388.711 + 3285.769 = R$12,873 Mil.
Average Total Assets from the begining of last year (Jul24)
to the end of last year (Jul25) was
(35096.894 + 36315.366 + 44118.539 + 44963.678 + 44262.429) / 5 = R$40951.3812 Mil. Total Assets at the begining of last year (Jul24) was R$35,097 Mil. Long-Term Debt & Capital Lease Obligation was R$414 Mil. Total Current Assets was R$38,702 Mil. Total Current Liabilities was R$6,944 Mil.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Veeva Systems's current Net Income (TTM) was 5,284.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Veeva Systems's return on assets of this year was 0.11938138. Veeva Systems's return on assets of last year was 0.13252614.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Veeva Systems's gearing of this year was 0.01535902. Veeva Systems's gearing of last year was 0.01010467.
==> Last year is lower than this year ==> Score 0.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Veeva Systems's current ratio of this year was 5.45776083. Veeva Systems's current ratio of last year was 5.57314169.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Veeva Systems's number of shares in issue this year was 4956.667. Veeva Systems's number of shares in issue last year was 5035.586.
==> There is smaller number of shares in issue this year, or the same. ==> Score 1.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Veeva Systems's gross margin of this year was 0.74961227. Veeva Systems's gross margin of last year was 0.7559392.
==> Last year's gross margin is higher ==> Score 0.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Veeva Systems's asset turnover of this year was 0.40689154. Veeva Systems's asset turnover of last year was 0.48521536.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
0
+
1
+
0
+
0
+
1
+
0
+
0
=
4
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Veeva Systems has an F-score of 4 indicating the company's financial situation is typical for a stable company.
Veeva Systems (BSP:V2EE34) has a Piotroski F-Score of 4 as of Sep. 03, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Veeva Systems and its competitors. This is 33% below median its historical median of 6.00. Over the past decade, Veeva Systems' Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Veeva Systems ranks #444 out of 645 companies in the Healthcare Providers & Services industry, placing it in the top 68.8%.
Is Veeva Systems' Piotroski F-Score too high?
Veeva Systems' current Piotroski F-Score of 4 is 33% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Veeva Systems' value of 4 is 20% below this industry median. Based on the distribution chart, Veeva Systems ranks #444 out of 645 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Veeva Systems has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' Piotroski F-Score compare to BTSG and TEM?
According to the Healthcare Providers & Services industry distribution chart, Veeva Systems ranks #444 out of 645 companies for Piotroski F-Score. This places Veeva Systems in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Veeva Systems' value of 4 is 20% below this benchmark. Historically, Veeva Systems' own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Veeva Systems has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veeva Systems's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Veeva Systems and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veeva Systems's current Piotroski F-Score is 4, which is 33% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (BSP:V2EE34) is currently considered Fairly Valued. The stock's GF Value™ is R$44.73, compared to a current price of R$47.66 — trading 6.6% above its estimated fair value. The current Piotroski F-Score is 4, which is 33% below median its 10-year median of 6.00 and 20% below the Healthcare Providers & Services industry median of 5.00. Veeva Systems' overall GF Score™ is 96/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Veeva Systems (BSP:V2EE34), the current Piotroski F-Score is 4 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (BSP:V2EE34) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be overvalued.
The current stock price of R$47.66 is trading 6.6% above its estimated GF Value™ of R$44.73.
GuruFocus considers Veeva Systems to be Fairly Valued.
Key valuation signals for BSP:V2EE34:
Piotroski F-Score: 4 (33% below median its 10-year median of 6.00)
GF Value™: R$44.73 vs. price of R$47.66 (6.6% above fair value)
Industry Position: 20% below the Healthcare Providers & Services median (#444 of 645)
No single metric tells the full story. See the BSP:V2EE34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
96GF Score
Get the complete analysis for BSP:V2EE34
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:V2EE34 has been successfully added to your 
